These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 6648019)
41. Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma. Wils J; Schlangen J; Naus A Recent Results Cancer Res; 1986; 100():157-62. PubMed ID: 3755539 [No Abstract] [Full Text] [Related]
42. Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma. Wils J; Schlangen J; Naus A Cancer Chemother Pharmacol; 1984; 13(3):215-7. PubMed ID: 6548420 [TBL] [Abstract][Full Text] [Related]
43. Regional chemotherapy of colorectal cancer metastatic to the liver. Niederhuber JE; Ensminger W; Gyves J; Thrall J; Walker S; Cozzi E Cancer; 1984 Mar; 53(6):1336-43. PubMed ID: 6229326 [TBL] [Abstract][Full Text] [Related]
44. Results of 27 cases with hepatic metastases treated by combination chemotherapy. Priestman TJ; Hanham IW Br J Cancer; 1972 Dec; 26(6):466-72. PubMed ID: 4647397 [TBL] [Abstract][Full Text] [Related]
46. Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy. Alexander HR; Libutti SK; Pingpank JF; Bartlett DL; Helsabeck C; Beresneva T Ann Surg Oncol; 2005 Feb; 12(2):138-44. PubMed ID: 15827794 [TBL] [Abstract][Full Text] [Related]
47. [Chemotherapy of cancer of the large intestine]. Platinskiĭ LV; Sokolova VD; Ozhiganov EL Sov Med; 1985; (3):51-8. PubMed ID: 3895460 [No Abstract] [Full Text] [Related]
49. [Intra-arterial chemotherapy of colorectal liver metastases with 5-fluorouracil (5-FU) and mitomycin C (MMC)]. Weder W; Roethlin M; Metzger U; Largiadèr F Helv Chir Acta; 1987 Dec; 54(4):383-6. PubMed ID: 3128495 [No Abstract] [Full Text] [Related]
50. Prognostic factors in patients with liver metastases from colorectal carcinoma treated with discontinuous intra-arterial hepatic chemotherapy. Rougier P; Ducreux M; Pignon JP; Elias D; Tigaud JM; Lumbroso J; Ruffie P; Lasser PH Eur J Cancer; 1991; 27(10):1226-30. PubMed ID: 1835591 [TBL] [Abstract][Full Text] [Related]
51. Current status of regional arterial infusion chemotherapy. Oberfield RA Med Clin North Am; 1975 Mar; 59(2):411-24. PubMed ID: 163944 [TBL] [Abstract][Full Text] [Related]
52. [Chemotherapy of colorectal cancers and of their hepatic metastases]. Jacquillat C; Hauchecorne J; Auclerc G Ann Gastroenterol Hepatol (Paris); 1985 Dec; 21(6):355-6. PubMed ID: 4096496 [No Abstract] [Full Text] [Related]
53. The implanted pump in metastatic colorectal cancer of the liver. Risk versus benefit. Johnson LP; Rivkin SE Am J Surg; 1985 May; 149(5):595-8. PubMed ID: 3158217 [TBL] [Abstract][Full Text] [Related]
54. Current protocol approaches in large bowel cancer. Carter SK Semin Oncol; 1976 Dec; 3(4):433-43. PubMed ID: 793018 [No Abstract] [Full Text] [Related]
55. [Chemotherapy of metastasizing cancers of the colon and rectum]. Piedbois P; Lévy E; Le Bourgeois JP; Buyse M Ann Chir; 1993; 47(6):480-3. PubMed ID: 7692804 [No Abstract] [Full Text] [Related]
56. Adjuvant and palliative treatment of colorectal cancer with fluorinated pyrimidines. A pharmacological and clinical review. Gustavsson B; Hafström L Acta Chir Scand Suppl; 1981; 504():1-28. PubMed ID: 6176091 [No Abstract] [Full Text] [Related]
57. Hepatic artery infusion chemotherapy with the Infusaid pump: a Canadian experience. Winton TL; Ghent WR Can J Surg; 1986 Sep; 29(5):379-80. PubMed ID: 2944572 [TBL] [Abstract][Full Text] [Related]
58. Ultrastructural changes in the dog liver cell after isolated liver perfusion with various cytotoxins. Merker G; Helling HJ; Krahl M; Aigner K Recent Results Cancer Res; 1983; 86():103-9. PubMed ID: 6685901 [TBL] [Abstract][Full Text] [Related]